These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2332779)

  • 41. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
    Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
    Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
    Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL
    Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
    Beale AS; Gisby J
    J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.
    Lamothe F; Auger F; Lacroix JM
    Antimicrob Agents Chemother; 1984 May; 25(5):662-5. PubMed ID: 6732233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
    Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Mar; 13(3):389-93. PubMed ID: 122520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Augmentation of the in vitro activity of azlocillin against Bacteroides fragilis by clavulanic acid.
    Bansal MB; Chuah SK; Thadepalli H
    Antimicrob Agents Chemother; 1984 Oct; 26(4):606-7. PubMed ID: 6517552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bactericide activity of cefadroxil comparated with amoxicillin-clavulanic acid, cefaclor and josamycin].
    Etesse-Carsenti H; Caillon J; Mondain V; Durant J; Bernard E; Dellamonica P; Drugeon HB
    Pathol Biol (Paris); 1991 Sep; 39(7):658-67. PubMed ID: 1758716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In vitro susceptibilities of BRL 25000 (clavulanic acid-amoxicillin) against causative organisms in the field of obstetrics and gynecology].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Yoshihara H; Oda S; Matsumoto Y; Ikegami R; Sato K
    Jpn J Antibiot; 1986 Mar; 39(3):842-52. PubMed ID: 3488425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
    Soriano F; Ponte MC; Gaspar MC
    J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The drug combination amoxicillin-clavulanic acid compared to the triple combination ampicillin-gentamicin-metronidazole in the treatment of severe adnexal infections].
    Ciraru-Vigneron N; Bercau G; Sauvanet E; Nguyen Tan Lung R; Felten A; Leaute JB; Zylbertrest T; Barrier J
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):665-8. PubMed ID: 3534764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antibacterial and bactericidal activity of tinidazole against anaerobic bacteria comparing with metronidazole (author's transl)].
    Ninomiya K; Kobata S; Imamura H; Mochizuki I; Watanabe K
    Jpn J Antibiot; 1976 Mar; 29(3):325-31. PubMed ID: 1271586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Scand J Infect Dis; 1985; 17(3):311-21. PubMed ID: 3903976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
    Maskell JP; Nasu M; Williams JD
    J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bactericidal activity of tinidazole. An in vitro comparison of the effects of tinidazole and metronidazole against Bacteroides fragilis and other Anaerobic bacteria.
    Jokipii AM; Jokipii L
    Chemotherapy; 1977; 23(1):25-31. PubMed ID: 318974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The activity of ticarcillin in combination with clavulanic acid against Bacteroides species: an in-vitro comparison with other antibiotics.
    de Barbeyrac B; Quentin C; Bébéar C
    J Antimicrob Chemother; 1986 May; 17 Suppl C():35-9. PubMed ID: 3636337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group.
    Malouin F; Lamothe F
    Can J Microbiol; 1987 Mar; 33(3):262-6. PubMed ID: 3105858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of cefazolin and two beta-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis.
    Fekete T; McGowen J; Cundy KR
    Antimicrob Agents Chemother; 1987 Feb; 31(2):321-2. PubMed ID: 3032097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.